Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by proneon Mar 09, 2021 10:39am
108 Views
Post# 32752007

Should help ................

Should help ................

Mexico's landmark cannabis bill one step closer to becoming law

10 hours ago by Thomson Reuters
 

MEXICO CITY, March 8 (Reuters) - Two special committees of Mexico's Lower House of Congress late on Monday

-->approved a draft bill to decriminalize marijuana and sent it on to the full chamber, bringing it a step closer to creating one of the world's largest markets for the drug.

The bill, backed by the administration of President Andres Manuel Lopez Obrador, would mark a major shift in a country bedeviled for years by violence between feuding drug cartels.

The health and justice committees approved the bill, which easily passed the Senate in a vote in November and would create a huge new legal market for marijuana that companies are eager to tap.

Colombian-Canadian Khiron Life Sciences, Canada's Canopy Growth and The Green Organic Dutchman , as well as Medical Marijuana from California are among other firms eyeing Mexico.

The full chamber of the Lower House is scheduled

-->to discuss the bill on Tuesday, two congressional sources told Reuters.

The bill would create the Mexican Institute for the Regulation and Control of Cannabis, which will issue five types of licenses for the cultivation, transformation, sale, research and export or import of marijuana.

Only people 18 years and older, and with a permit, may grow, carry or consume marijuana and its derivatives, according to the bill, which Lopez Obrador's ruling MORENA party proposed. MORENA has a majority in both chambers of Congress.

Lopez Obrador has argued that decriminalizing cannabis and other narcotics could help combat Mexico's powerful drug cartels.

(Reporting by Diego Ore; Additional reporting by Sharay Angulo; Writing by Anthony Esposito. Editing by Gerry Doyle)

<< Previous
Bullboard Posts
Next >>